Interannual variation, ecological risk and human health risk of heavy metals in oyster-cultured sediments in the Maowei Estuary, China, from 2011 to 2018.

Mar Pollut Bull

Key Laboratory of Environment Change and Resources Use in Beibu Gulf, Nanning Normal University, Ministry of Education, Nanning 530001, China; Guangxi Key Laboratory of Earth Surface Processes and Intelligent Simulation, Nanning Normal University, Nanning 530001, China.

Published: May 2020

Heavy metals (HMs) in aquaculture-influenced sediments pose a threat to both aquatic ecosystems and human health via aquatic product intake. Based on a long-term (from 2011 to 2018) study, the concentrations of five HMs in oyster-cultured sediments in the Maowei Estuary, China, were ranked as follows: Pb (17.58 ± 10.82 mg/kg) > Cu (17.15 ± 8.61 mg/kg) > As (10.27 ± 5.24 mg/kg) > Cd (0.16 ± 0.14 mg/kg) > Hg (0.067 ± 0.033 mg/kg). These concentrations were all close to the guide values in China and those reported in other studies. However, through the Mann-Kendall test, Cu showed obvious increasing interannual trends, and according to ecological risk assessment, the sediments were highly contaminated with Cu and Hg. The health risks to local residents via oyster intake showed that both noncarcinogenic and carcinogenic risk did not exceed the safety criteria (THQ = 1, TCR = 10). The current study suggests that ecological and human health risks be integrated to control HMs in the Maowei Estuary.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.marpolbul.2020.111039DOI Listing

Publication Analysis

Top Keywords

human health
12
maowei estuary
12
ecological risk
8
heavy metals
8
oyster-cultured sediments
8
sediments maowei
8
estuary china
8
2011 2018
8
health risks
8
interannual variation
4

Similar Publications

Background: Epstein-Barr virus (EBV) is implicated as a necessary factor in the development of multiple sclerosis (MS) and may also be a driver of disease activity. Although it is not clear whether ongoing viral replication is the driver for MS pathology, MS researchers have considered the prospect of using drugs with potential efficacy against EBV in the treatment of MS. We have undertaken scientific and lived experience expert panel reviews to shortlist existing licensed therapies that could be used in later-stage clinical trials in MS.

View Article and Find Full Text PDF

Purpose: Mammary carcinoma is comprised heterogeneous groups of cells with different metastatic potential. 4T1 mammary carcinoma cells metastasized to heart (4THM), liver (4TLM) and brain (4TBM) and demonstrate cancer-stem cell phenotype. Using these cancer cells we found thatTGF-β is the top upstream regulator of metastatic process.

View Article and Find Full Text PDF

Purpose Of Review: This article discusses a tailored approach to managing cardiogenic shock and temporary mechanical circulatory support (tMCS). We also outline specific mobilization strategies for patients with different tMCS devices and configurations, which can be enabled by this tailored approach to cardiogenic shock management.

Recent Findings: Safe and effective mobilization of patients with cardiogenic shock receiving tMCS can be accomplished.

View Article and Find Full Text PDF

The development of probes for the efficient detection of volatile organic compounds is crucial for both human health protection and environmental monitoring. In this study, we successfully synthesized a ratiometric fluorescent sensing material [Eu-UiO-67 (1:1)], featuring dual-emission fluorescence peaks via a one-pot method. This material demonstrated exceptional ratiometric fluorescence recognition properties for liquid styrene and isoprene, achieving low limit of detections (LODs) of 6.

View Article and Find Full Text PDF

Therapeutic decision-making for older patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer highlights the importance of a comprehensive geriatric assessment (CGA). This assessment considers the functional status, comorbidities, and relevant conditions of the patient, and allows for an estimation of life expectancy, but it does not facilitate individualized treatment plans. There are also other challenges to consider related to the cardiac toxicity of the treatments and the under-representation of older patients in clinical trials.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!